Literature DB >> 20890998

Cytologic findings and potential pitfalls in proliferative myositis and myositis ossificans diagnosed by fine needle aspiration cytology: report of four cases and review of the literature.

Eirini Klapsinou1, Proestou Despoina, Daskalopoulou Dimitra.   

Abstract

Proliferative myositis (PM) and myositis ossificans (MO) are two uncommon, benign pseudosarcomatous lesions of soft tissue. Despite their benign nature, they are often misdiagnosed for malignant soft tissue tumors because of their alarming clinical presentation. Fine needle aspiration cytology (FNAC) is a quick and simple method that can accurately diagnose such lesions, provided that the cytopathologist is adequately familiar with the cytomorphological features of these lesions as opposed to the features of sarcomas. In this report, we present three cases of PM and one case of MO diagnosed by FNAC. Their cytomorphological features are described, and related literature is reviewed.
Copyright © 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20890998     DOI: 10.1002/dc.21549

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  4 in total

1.  Pseudomalignant myositis ossificans in the breast: A case report.

Authors:  Kamil Pohlodek; Miroslav Janík; Iveta Mečiarová; František Ondriaš
Journal:  Mol Clin Oncol       Date:  2018-04-13

2.  Proliferative myositis in the right brachioradialis: A case report.

Authors:  Na Wei; Wei-Jie Xu; Dong Dong; Yu-Bao Gong
Journal:  Exp Ther Med       Date:  2017-03-28       Impact factor: 2.447

3.  Bone tumor mimickers: A pictorial essay.

Authors:  Jennifer Ni Mhuircheartaigh; Yu-Ching Lin; Jim S Wu
Journal:  Indian J Radiol Imaging       Date:  2014-07

4.  Left abdominal wall proliferative myositis resection and patch repair: A case report.

Authors:  Ren-Wei Xing; Han-Qiu Nie; Xian-Fei Zhou; Fang-Fang Zhang; Yong-Hua Mou
Journal:  World J Clin Cases       Date:  2022-02-26       Impact factor: 1.337

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.